Compare SNT & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNT | SEER |
|---|---|---|
| Founded | 1965 | 2017 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 97.3M |
| IPO Year | 2023 | 2020 |
| Metric | SNT | SEER |
|---|---|---|
| Price | $2.96 | $1.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.9K | ★ 295.4K |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | N/A | $25.90 |
| P/E Ratio | $19.22 | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $2.57 | $1.62 |
| 52 Week High | $5.34 | $2.41 |
| Indicator | SNT | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 29.41 | 36.93 |
| Support Level | $2.75 | N/A |
| Resistance Level | $4.54 | $1.97 |
| Average True Range (ATR) | 0.16 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 3.82 | 2.63 |
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.